Form 4 for PRLD Prelude Therapeutics Inc
Accepted 2022-03-22 00:00:00 ET · period of report 2022-03-21 · accession 0001209191-22-020585 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-22 | 2022-03-21 | PRLD | Chardonnet Laurent | CFO | A - Grant | $7.51 | +6,500 | 14.5K | +81% | +$48.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-21 | A | A | 6,500 | $7.51 | 14,500 | D | — | — |